Related references
Note: Only part of the references are listed.Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome
Giustina Ferone et al.
EMBO MOLECULAR MEDICINE (2012)
Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
Soren Lehmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis
R. Shalom-Feuerstein et al.
CELL DEATH AND DIFFERENTIATION (2011)
p63, a Story of Mice and Men
Hans Vanbokhoven et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Embryonic stem cells as an ectodermal cellular model of human p63-related dysplasia syndromes
Philippe Rostagno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Rapp-Hodgkin and Hay-Wells ectodermal dysplasia syndromes represent a variable spectrum of the same genetic disorder
S. E. Clements et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes
Ralf D. Kirschner et al.
CELL CYCLE (2010)
PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73
N. Rokaeus et al.
ONCOGENE (2010)
Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
K. G. Wiman
ONCOGENE (2010)
Genome-Wide Profiling of p63 DNA-Binding Sites Identifies an Element that Regulates Gene Expression during Limb Development in the 7q21 SHFM1 Locus
Evelyn N. Kouwenhoven et al.
PLOS GENETICS (2010)
PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
Jeremy M. R. Lambert et al.
CANCER CELL (2009)
Cytoplasmic functions of the tumour suppressor p53
Douglas R. Green et al.
NATURE (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Restoration of p53 to limit tumor growth
Wenge Wang et al.
CURRENT OPINION IN ONCOLOGY (2008)
Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects
Nadia Lo Iacono et al.
DEVELOPMENT (2008)
Claudin-1 Is a p63 Target Gene with a Crucial Role in Epithelial Development
Teresa Lopardo et al.
PLOS ONE (2008)
Shaping genetic alterations in human cancer: The p53 mutation paradigm
Thierry Soussi et al.
CANCER CELL (2007)
TAp63 and ΔNp63 in cancer and epidermal development
Eleonora Candi et al.
CELL CYCLE (2007)
Pattern of p63 mutations and their phenotypes- : Update
Tuula Rinne et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
p63 is the molecular switch for initiation of an epithelial stratification program
MI Koster et al.
GENES & DEVELOPMENT (2004)
A null mutation in the cystatin M/E gene of ichq mice causes juvenile lethality and defects in epidermal cornification
PLJM Zeeuwen et al.
HUMAN MOLECULAR GENETICS (2002)
Splitting p63
H van Bokhoven et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
A dominant-negative form of p63 is required for epidermal proliferation in zebrafish
H Lee et al.
DEVELOPMENTAL CELL (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63
JA McGrath et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
